Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Current Liabilities: 2024

Historic Total Current Liabilities for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $78.7 million.

  • Kura Oncology's Total Current Liabilities rose 200.47% to $121.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.3 million, marking a year-over-year increase of 200.47%. This contributed to the annual value of $78.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Total Current Liabilities of $78.7 million as of FY2024.
  • In the past 5 years, Kura Oncology's Total Current Liabilities ranged from a high of $78.7 million in FY2024 and a low of $78.7 million during FY2024.
  • Over the past 1 years, Kura Oncology's median Total Current Liabilities value was $78.7 million (recorded in 2024), while the average stood at $78.7 million.